The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulati
about
sameAs
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulati
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The feasibility of classical c ...... e intensity (RDI) and cumulati
@en
The feasibility of classical c ...... e intensity (RDI) and cumulati
@nl
type
label
The feasibility of classical c ...... e intensity (RDI) and cumulati
@en
The feasibility of classical c ...... e intensity (RDI) and cumulati
@nl
prefLabel
The feasibility of classical c ...... e intensity (RDI) and cumulati
@en
The feasibility of classical c ...... e intensity (RDI) and cumulati
@nl
P2093
P356
P1433
P1476
The feasibility of classical c ...... tive doses across institutions
@en
P2093
A F Ferreira Filho
A Vindevoghel
M Beauduin
M J Piccart
M Paesmans
S Bartholomeus
P304
P356
10.1093/ANNONC/MDF051
P407
P577
2002-03-01T00:00:00Z